Conservative management ectopic pregnancy prospective clinical trial methotrexate versus sulprostone combined transvaginal systemic administration prospective randomized study patients unruptured tubal pregnancy local systemic injection day diagnosis methotrexate MTX mg/kg sulprostone micrograms gestational sac transvaginal sonographic control systemic component intramuscular injection MTX mg/kg days local injection sulprostone micrograms postlocal injection days Methotrexate therapy successful patients sulprostone therapy Laparoscopy unsuccessful patients pain hemoperitoneum human choriogonadotropin hCG levels stomatitis MTX abdominal pain Thirteen treated patients initial hCG levels mIU/mL subsequent hysterosalpinography patients normal tubal configuration patency patients pregnancy normal intrauterine pregnancy results MTX sulprostone effective medical approach unruptured ectopic pregnancy patients hCG mIU/mL 